|
|
Volumn 7, Issue 1, 2009, Pages 35-40
|
|
Phase II designs for anticancer botanicals and supplements
|
|
Author keywords
Complementary medicine; Research design
|
|
Indexed keywords
ANGIOGENESIS INHIBITOR;
ANTINEOPLASTIC AGENT;
CYTOTOXIC AGENT;
NATURAL PRODUCT;
PLATINUM COMPLEX;
TAXANE DERIVATIVE;
ADVANCED CANCER;
ALTERNATIVE MEDICINE;
ANTIANGIOGENIC ACTIVITY;
CANCER CHEMOTHERAPY;
CANCER INHIBITION;
CANCER REGRESSION;
CANCER SURVIVAL;
CLINICAL TRIAL;
COMORBIDITY;
DRUG EFFICACY;
HUMAN;
MALIGNANT NEOPLASTIC DISEASE;
PREDICTION;
PROGRESSION FREE SURVIVAL;
SHORT SURVEY;
STATISTICAL ANALYSIS;
SUPPLEMENTATION;
TREATMENT RESPONSE;
ARTICLE;
METHODOLOGY;
NEOPLASM;
PHASE 2 CLINICAL TRIAL;
PHYTOTHERAPY;
ANTINEOPLASTIC AGENTS, PHYTOGENIC;
CLINICAL TRIALS, PHASE II AS TOPIC;
COMPLEMENTARY THERAPIES;
HUMANS;
NEOPLASMS;
PHYTOTHERAPY;
RESEARCH DESIGN;
|
|
EID: 67149106136
PISSN: 1715894X
EISSN: None
Source Type: Journal
DOI: 10.2310/7200.2009.0006 Document Type: Short Survey |
|
Times cited : (1)
|
|
References (0)
|
